P953: ROLE OF THE COMBINATION OF FDG PET PLUS WHOLE BODY MRI FOR STAGING NEWLY DIAGNOSED AND RELAPSED/REFRACTORY MULTIPLE MYELOMA: A PROSPECTIVE TRIAL
Main Authors: | Claudio Cerchione, Davide Nappi, Matteo Marchesini, Giacomo Feliciani, Andrea Prochowski Iamurri, Sonia Ronconi, Delia Cangini, Michela Ceccolini, Claudia Matuozzo, Fabiana Mammoli, Federica Frabetti, Giovanni Paganelli, Federica Matteucci, Caterina Pallotti, Emanuela Scarpi, Chiara Pazzi, Domenico Barone, Antonino Romeo, Giorgia Simonetti, Gerardo Musuraca, Giovanni Martinelli, Alice Rossi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000970716.33151.14 |
Similar Items
-
P918: ROLE OF THE COMBINATION OF FDG PET PLUS WHOLE BODY MRI FOR STAGING PATIENTS IN HIGH RISK SMOLDERING MYELOMA: A PROSPECTIVE TRIAL
by: Claudio Cerchione, et al.
Published: (2023-08-01) -
PB1985: CHEMO OR CHEMO-FREE REGIMENS IN HEAVILY PRETREATED MULTIPLE MYELOMA? ROLE OF BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN NOVEL AGENTS’ ERA
by: C. Cerchione, et al.
Published: (2022-06-01) -
PB1986: ADDITION OF CARFILZOMIB AS A THIRD AGENT IN LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: SWITCHING FROM DOUBLET TO TRIPLET
by: C. Cerchione, et al.
Published: (2022-06-01) -
PB1987: DOMESTIC OPPORTUNITY IN HEAVILY PRETREATED MULTIPLE MYELOMA NOT ELIGIBLE TO HOSPITAL-BASED TREATMENT: ROLE OF POMALIDOMIDE-DEXAMETHASONE
by: C. Cerchione, et al.
Published: (2022-06-01) -
PB2262: PEGFILGRASTIM IN THE SUPPORTIVE CARE OF HEAVILY PRETREATED MULTIPLE MYELOMA IN POMALIDOMIDE-BASED TREATMENT
by: C. Cerchione, et al.
Published: (2022-06-01)